Literature DB >> 19444620

Preparation and characterization of co-grinded mixtures of aceclofenac and neusilin US2 for dissolution enhancement of aceclofenac.

Ambarish H Vadher1, Jolly R Parikh, Rajesh H Parikh, Ajay B Solanki.   

Abstract

The present study was carried out with a view to enhance the dissolution of poorly water-soluble BCS-class II drug aceclofenac by co-grinding with novel porous carrier Neusilin US(2.) (amorphous microporous granules of magnesium aluminosilicate, Fuji Chemical Industry, Toyama, Japan). Neusilin US(2) has been used as an important pharmaceutical excipient for solubility enhancement. Co-grinding of aceclofenac with Neusilin US(2) in a ratio of 1:5 was carried out by ball milling for 20 h. Samples of co-ground mixtures were withdrawn at the end of every 5 h. and characterized for X-ray powder diffraction, differential scanning calorimetry, and Fourier-transform infrared spectroscopy. The analysis revealed the conversion of crystalline aceclofenac to its amorphous form upon milling with Neusilin US(2). Further, in vitro dissolution rate of aceclofenac from co-ground mixture was significantly higher compared to pure aceclofenac. The accelerated stability study of co-ground mixture was carried out at 40 degrees C/75%RH for 4 weeks, and it showed that there was no reversion from amorphous to crystalline form. Thus, it is advantageous to use a porous carrier like Neusilin US(2) in improvement of dissolution of poorly soluble drugs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19444620      PMCID: PMC2690784          DOI: 10.1208/s12249-009-9221-6

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  28 in total

1.  What is the true solubility advantage for amorphous pharmaceuticals?

Authors:  B C Hancock; M Parks
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

2.  Influence of alkali metal counterions on the glass transition temperature of amorphous indomethacin salts.

Authors:  Ping Tong; Lynne S Taylor; George Zografi
Journal:  Pharm Res       Date:  2002-05       Impact factor: 4.200

3.  Use of commercial porous ceramic particles for sustained drug delivery.

Authors:  R S Byrne; P B Deasy
Journal:  Int J Pharm       Date:  2002-10-10       Impact factor: 5.875

4.  Determination of aceclofenac in bulk and pharmaceutical formulations.

Authors:  N H Zawilla; M Abdul Azim Mohammad; N M El Kousy; S M El-Moghazy Aly
Journal:  J Pharm Biomed Anal       Date:  2002-01-01       Impact factor: 3.935

5.  Stability of amorphous indomethacin compounded with silica.

Authors:  T Watanabe; N Wakiyama; F Usui; M Ikeda; T Isobe; M Senna
Journal:  Int J Pharm       Date:  2001-09-11       Impact factor: 5.875

6.  Mechanism for further enhancement in drug dissolution from solid-dispersion granules upon storage.

Authors:  Manish K Gupta; Robin H Bogner; David Goldman; Yin-Chao Tseng
Journal:  Pharm Dev Technol       Date:  2002-01       Impact factor: 3.133

7.  Enhanced drug dissolution and bulk properties of solid dispersions granulated with a surface adsorbent.

Authors:  M K Gupta; D Goldman; R H Bogner; Y C Tseng
Journal:  Pharm Dev Technol       Date:  2001-11       Impact factor: 3.133

8.  Improvement of solubility and oral bioavailability of a poorly water-soluble drug, TAS-301, by its melt-adsorption on a porous calcium silicate.

Authors:  Masahiro Kinoshita; Kazuhiko Baba; Atushi Nagayasu; Kanoo Yamabe; Takashi Shimooka; Yoh'ichiro Takeichi; Mami Azuma; Hitoshi Houchi; Kazuo Minakuchi
Journal:  J Pharm Sci       Date:  2002-02       Impact factor: 3.534

9.  Preparation and, in vitro, preclinical and clinical studies of aceclofenac spherical agglomerates.

Authors:  Achutha Nayak Usha; Srinivas Mutalik; Meka Sreenivasa Reddy; Averineni Kumar Ranjith; Pralhad Kushtagi; Nayanabhirama Udupa
Journal:  Eur J Pharm Biopharm       Date:  2008-06-19       Impact factor: 5.571

10.  Stabilization of amorphous indomethacin by co-grinding in a ternary mixture.

Authors:  Tomoyuki Watanabe; Ikumasa Ohno; Naoki Wakiyama; Akira Kusai; Mamoru Senna
Journal:  Int J Pharm       Date:  2002-07-08       Impact factor: 5.875

View more
  10 in total

1.  Dissolution and solid-state characterization of poorly water-soluble drugs in the presence of a hydrophilic carrier.

Authors:  Rahmat Talukder; Chase Reed; Thomas Dürig; Muhammad Hussain
Journal:  AAPS PharmSciTech       Date:  2011-09-20       Impact factor: 3.246

2.  Physicomechanical, stability, and pharmacokinetic evaluation of aceclofenac dimethyl urea cocrystals.

Authors:  Hafsa Afzal; Nasir Abbas; Amjad Hussain; Sumera Latif; Kanwal Fatima; Muhammad Sohail Arshad; Nadeem Irfan Bukhari
Journal:  AAPS PharmSciTech       Date:  2021-02-09       Impact factor: 3.246

3.  Development, characterisation and evaluation of supersaturated triglyceride free drug delivery (s-TFDDS) of lornoxicam.

Authors:  D M Bramhane; N V Jadhav; P R Vavia
Journal:  Drug Deliv Transl Res       Date:  2013-10       Impact factor: 4.617

4.  Dissolution enhancement of atorvastatin calcium by co-grinding technique.

Authors:  Priyanka Prabhu; Vandana Patravale
Journal:  Drug Deliv Transl Res       Date:  2016-08       Impact factor: 4.617

5.  Effect of pH Modifiers on the Solubility, Dissolution Rate, and Stability of Telmisartan Solid Dispersions Produced by Hot-melt Extrusion Technology.

Authors:  Ahmed Almotairy; Mashan Almutairi; Abdulmajeed Althobaiti; Mohammed Alyahya; Sandeep Sarabu; Abdullah Alzahrani; Feng Zhang; Suresh Bandari; Michael A Repka
Journal:  J Drug Deliv Sci Technol       Date:  2021-06-29       Impact factor: 5.062

6.  Development of a mini-tablet of co-grinded prednisone-Neusilin complex for pediatric use.

Authors:  H Lou; M Liu; L Wang; S R Mishra; W Qu; J Johnson; E Brunson; H Almoazen
Journal:  AAPS PharmSciTech       Date:  2013-06-13       Impact factor: 3.246

7.  Dissolution enhancement of chlorzoxazone using cogrinding technique.

Authors:  Mihir K Raval; Jaydeep M Patel; Rajesh K Parikh; Navin R Sheth
Journal:  Int J Pharm Investig       Date:  2015 Oct-Dec

8.  Design and Characterization of Phosphatidylcholine-Based Solid Dispersions of Aprepitant for Enhanced Solubility and Dissolution.

Authors:  Sooho Yeo; Jieun An; Changhee Park; Dohyun Kim; Jaehwi Lee
Journal:  Pharmaceutics       Date:  2020-04-29       Impact factor: 6.321

9.  Insight into the Inclusion Complexation of Fluconazole with Sulfonatocalix[4]naphthalene in Aqueous Solution, Solid-State, and Its Antimycotic Activity.

Authors:  Tayel A Al Hujran; Mousa K Magharbeh; Almeqdad Y Habashneh; Rasha S Al-Dmour; Ashraf Aboelela; Hesham M Tawfeek
Journal:  Molecules       Date:  2022-07-11       Impact factor: 4.927

10.  Formulation development and optimization of fast dissolving tablets of aceclofenac using natural superdisintegrant.

Authors:  Lovleen Kaur; Rajni Bala; Neha Kanojia; Manju Nagpal; Gitika Arora Dhingra
Journal:  ISRN Pharm       Date:  2014-05-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.